hydroxyurea has been researched along with stavudine in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (40.43) | 18.2507 |
2000's | 19 (40.43) | 29.6817 |
2010's | 8 (17.02) | 24.3611 |
2020's | 1 (2.13) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Ahluwalia, GS; Gao, WY; Johns, DG; Mitsuya, H | 1 |
Chiang, Y; Drake, RR; Govindarajan, R; Hume, SD; Krisa, S; McMasters, R; Munshi, NC; Rechtin, TM; Saylors, RL | 1 |
Loesch, K; Nokta, M; Pollard, RB; Rossero, R | 1 |
Bernasconi, E; Bucher, HC; Hirschel, B; Iten, A; Leduc, D; Malinverni, R; Opravil, M; Perrin, LH; Rutschmann, OT; Sudre, P; Vernazza, PL; Yerly, S | 1 |
Nichols, J; Nokta, M; Pollard, RB; Rosenbaum, M; Rossero, R | 1 |
Back, DJ; Barry, MG; Henry-Mowatt, JS; Hoggard, PG; Kewn, S; Sales, SD; Veal, GJ | 1 |
Hirschel, B; Marchal, F; Opravil, M; Perrin, L; Rutschmann, OT; Yerly, S | 1 |
Alexander, CS; Harrigan, PR; Mo, T; Montaner, JS; Raboud, JM; Rae, S; Rouleau, D; Zala, C | 1 |
Keruly, JC; McArthur, JC; Moore, RD; Wong, WM | 1 |
Cepeda, JA; Wilks, D | 1 |
Bernasconi, E; Bucher, H; Hirschel, B; Iten, A; Malinverni, R; Opravil, M; Perrin, LH; Rutschmann, OT; Vernazza, PL; Yerly, S | 1 |
Johnson, D | 1 |
Bernasconi, E; Bucher, HC; Fagard, C; Hirschel, B; Ledergerber, B; Leduc, D; Malinverni, R; Opravil, M; Perrin, L; Rutschmann, OT; Telenti, A; Vernazza, PL | 1 |
Calles, NR; Kline, MW; Schwarzwald, H; Simon, C | 1 |
Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA | 1 |
Chaisson, RE; Keruly, JC; Moore, RD | 1 |
Falkenberg, J; Gilden, D; Torres, G | 1 |
Davis, B; Zachary, KC | 1 |
Levin, J | 1 |
Cahn, P; Federico, A; Kijak, G; Montaner, JS; Ochoa, C; Perez, H; Salomon, H; Zala, C | 1 |
Bendele, RA; Richardson, FC | 1 |
Andron, L; Asmuth, DM; Grady, JJ; Green, S; McKinsey, DS; Pollard, RB; Rossero, R | 1 |
Dogruel, M; Gibbs, JE; Thomas, SA | 1 |
Bower, M; Gazzard, B; Mandalia, S; Nelson, M; Orkin, C; Pozniak, A; Stebbing, J | 1 |
Barasolo, G; Castelli, F; D'Aquila, R; Foli, A; Lisziewicz, J; Lori, F; Maggiolo, F; Maserati, R; Migliorino, M; Pan, A; Paolucci, S; Scudeller, L; Tinelli, C; Tomasoni, L | 1 |
Murphy, RL; Parker, RA; Redfield, RR; Reisler, RB | 1 |
Asmuth, D; Bakare, N; Blick, G; Farthing, C; Foli, A; Frank, I; Greiger, P; Groff, A; Herman, D; Lisziewicz, J; Lori, F; Lova, L; Norris, D; Peterson, D; Pollard, RB; Rashbaum, B; Schrader, S; Shalit, P; Tennenberg, A; Whitman, L | 1 |
Cahn, P; Salomón, H; Zala, C | 1 |
Lisziewicz, J; Lori, F | 1 |
2 review(s) available for hydroxyurea and stavudine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effects.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine | 1999 |
12 trial(s) available for hydroxyurea and stavudine
Article | Year |
---|---|
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Middle Aged; Prospective Studies; RNA, Viral; Stavudine; Switzerland; Viremia | 1998 |
Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lymph Nodes; RNA, Viral; Stavudine; Viral Load | 1999 |
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hydroxyurea; Lamivudine; Logistic Models; Mutation; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zidovudine | 2000 |
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Synergism; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydroxyurea; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine | 1998 |
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
Topics: Anti-HIV Agents; Diarrhea; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydroxyurea; Nausea; Peripheral Nervous System Diseases; Stavudine | 2000 |
Hydroxyurea for HIV infection.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; DNA Replication; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Viral Load | 1998 |
Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Nevirapine; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viremia | 2002 |
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load; Zidovudine | 2003 |
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Hydroxyurea; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Phenotype; Salvage Therapy; Stavudine; Treatment Outcome; Viral Load | 2004 |
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; HIV-1; Humans; Hydroxyurea; Indinavir; Italy; RNA, Viral; Stavudine; Time Factors; Viral Load; Viremia | 2004 |
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Drug Therapy, Combination; HIV-1; Humans; Hydroxyurea; Incidence; Indinavir; National Institutes of Health (U.S.); Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States | 2005 |
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Hydroxyurea; Male; RNA, Viral; Stavudine; Viral Load; Viremia | 2005 |
33 other study(ies) available for hydroxyurea and stavudine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.
Topics: Amides; Biotransformation; Biphenyl Compounds; Cell Line; Deoxyguanosine; Floxuridine; HIV; HIV Reverse Transcriptase; HIV-1; Humans; Hydroxyurea; Kinetics; Methotrexate; Models, Biological; Phosphorylation; Pyrazoles; Reverse Transcriptase Inhibitors; Ribonucleosides; Ribose; RNA-Directed DNA Polymerase; Stavudine; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured | 1996 |
Metabolism and activities of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine in herpesvirus thymidine kinase transduced T-lymphocytes.
Topics: Acyclovir; Cell Line; Dose-Response Relationship, Drug; Ganciclovir; Genetic Therapy; Growth Inhibitors; Herpesvirus 1, Human; HIV-1; Humans; Hydroxyurea; Nucleosides; Stavudine; Substrate Specificity; T-Lymphocytes; Thymidine Kinase; Zalcitabine; Zidovudine | 1997 |
Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
Topics: Adult; Anti-HIV Agents; Antigens, CD; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Kinetics; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Reverse Transcriptase Inhibitors; Solubility; Stavudine; Tumor Necrosis Factor-alpha; Viremia | 1997 |
Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
Topics: Adult; Anti-HIV Agents; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Didanosine; Drug Therapy, Combination; Female; Flow Cytometry; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Hydroxyurea; Immunologic Memory; Leukocyte Common Antigens; Lymphocyte Activation; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Stavudine; T-Lymphocyte Subsets; Viral Load | 1999 |
Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.
Topics: Anti-HIV Agents; Deoxyadenine Nucleotides; Didanosine; Dideoxynucleotides; Drug Interactions; Guanosine; Humans; Hydroxyurea; Inosine; Intracellular Fluid; Lamivudine; Pentoxifylline; Stavudine; U937 Cells; Zidovudine | 1999 |
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
Topics: Adult; Aged; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 2000 |
Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 2000 |
Principles of treating HIV.
Topics: Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Protease Inhibitors; Randomized Controlled Trials as Topic; Stavudine; Treatment Failure; Viral Load | 2000 |
Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Female; HIV Infections; Humans; Hydroxyurea; Infant; Male; Pilot Projects; RNA, Viral; Stavudine | 2000 |
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine | 2001 |
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
Topics: Adult; Amylases; Anti-HIV Agents; Didanosine; Female; HIV Infections; HIV-1; Humans; Hydroxyurea; Incidence; Lipase; Longitudinal Studies; Male; Pancreatitis; Reverse Transcriptase Inhibitors; Stavudine; United States; Zidovudine | 2001 |
Update on clinical trials of combination therapies for HIV infection.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; RNA-Directed DNA Polymerase; Stavudine; Zalcitabine; Zidovudine | 1995 |
Dethroning AZT.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Lamivudine; Oxazines; Stavudine; Viral Load; Zidovudine | 1997 |
Drug research shows easier dosing, new combinations are making gains.
Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Salvage Therapy; Stavudine; United States; Zidovudine | 1998 |
Hydroxyurea for HIV?
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Stavudine | 1998 |
Hydroxyurea - new observations.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Indinavir; Nucleic Acid Synthesis Inhibitors; Stavudine; Viral Load; Virus Replication | 1998 |
Interrupting HAART; Hydroxyurea; five+ drug therapy - report from the RIGHT Conference.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Stavudine | 1999 |
Extended warning on Didanosine-related pancreatitis.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Indinavir; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Stavudine | 1999 |
ddI, d4T, Hydroxyurea: new pancreatitis warning.
Topics: Anti-HIV Agents; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Nucleic Acid Synthesis Inhibitors; Pancreatitis; Stavudine; United States Food and Drug Administration | 1999 |
Adefovir nephrotoxicity and mitochondrial DNA depletion.
Topics: Adenine; Antiviral Agents; Clinical Trials, Phase III as Topic; Cyclooxygenase Inhibitors; DNA, Mitochondrial; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Kidney Tubules; Mitochondria; Organophosphonates; Renal Insufficiency; Stavudine | 2002 |
Hydroxyurea transport across the blood-brain and blood-cerebrospinal fluid barriers of the guinea-pig.
Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Carbon Radioisotopes; Cerebrospinal Fluid; Choroid Plexus; Guinea Pigs; Hydroxyurea; Mannitol; Perfusion; Pituitary Gland; Stavudine; Telencephalon; Time Factors; Tritium | 2003 |
Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
Topics: Acute Disease; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; Humans; Hydroxyurea; Nevirapine; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome | 1999 |